SS
INMB icon

SBI Securities’s INmune Bio INMB Stock Holding History

SBI Securities’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6K Buy
1,596
+763
+92% +$1.06K ﹤0.01% 2470
2026
Q1 		$941 Hold
833
– – ﹤0.01% 2678
2025
Q4 		$1.3K Sell
833
-4,715
-85% -$8.41K ﹤0.01% 2547
2025
Q3 		$11.5K Buy
5,548
+3,915
+240% +$8.96K ﹤0.01% 1707
2025
Q2 		$3.77K Sell
1,633
-11
-0.7% -$81 ﹤0.01% 2120
2025
Q1 		$12.8K Sell
1,644
-27
-2% -$214 ﹤0.01% 1503
2024
Q4 		$7.8K Buy
+1,671
New +$8.71K ﹤0.01% 1747

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities's INMB Position: Q2 2026 in Review

SBI Securities increased its INmune Bio (INMB) stake by 92% in Q2 2026, buying an estimated $1.06K and bringing the position to 1,596 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2470.

SBI Securities first reported a position in INMB in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.8K in Q1 2025. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • SBI Securities held 1,596 shares of INmune Bio worth $2.6K as of Q2 2026.
  • SBI Securities bought 763 INmune Bio shares in Q2 2026, an estimated $1.06K.
  • INmune Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2470 holding.
  • SBI Securities first reported a position in INmune Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's INmune Bio position peaked at $12.8K in Q1 2025.
  • 83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.